Back to Search
JEANIE LYNN COTE MD
MD
Neurology Physician
NPI: 1467771311IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obesity Medicine (Preventive Medicine) Physician
Preventive Medicine — Obesity Medicine
Code: 2083B0002X
4301096130(MI)
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
4301096130(MI)
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 2010
Research & Publications (20)
[Malignant mixed müllerian tumor of the uterus following tamoxifen for breast cancer: case report].
PMID 18249575·Gynecol Obstet Fertil·2008
5-case
Determinants of male fitness: disentangling intra- and inter-sexual selection.
PMID 17979954·J Evol Biol·2008
7-preclinical
Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers.
PMID 19004846·J Clin Pharmacol·2009
2-rct
Effect of sitagliptin on the pharmacokinetics of simvastatin.
PMID 19204138·J Clin Pharmacol·2009
2-rct
Carotenoid-based colours reflect the stress response in the common lizard.
PMID 19352507·PLoS One·2009
7-preclinical
Informed dispersal, heterogeneity in animal dispersal syndromes and the dynamics of spatially structured populations.
PMID 19170731·Ecol Lett·2009
7-preclinical
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers.
PMID 18258750·J Clin Pharmacol·2008
2-rct
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
PMID 18177726·Cell Metab·2008
2-rct
Lifetime and intergenerational fitness consequences of harmful male interactions for female lizards.
PMID 18376547·Ecology·2008
7-preclinical
Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects.
PMID 18287275·J Nucl Med·2008
8-other
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers.
PMID 18508950·J Clin Pharmacol·2008
2-rct
Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.
PMID 18580870·Clin Pharmacol Ther·2008
2-rct
Environmentally induced changes in carotenoid-based coloration of female lizards: a comment on Vercken et al.
PMID 18435721·J Evol Biol·2008
7-preclinical
Effects of fatigue on intermuscular coordination during repetitive hammering.
PMID 18483444·Motor Control·2008
8-other
Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.
PMID 18244953·Am J Respir Crit Care Med·2008
4-observational
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
PMID 17535893·Proc Natl Acad Sci U S A·2007
7-preclinical
Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.
PMID 17468348·Diabetes Care·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2525 JOLLY RD STE 240
OKEMOS, MI 48864 - Phone
- (989) 729-4304
Quick Facts
- NPI
- 1467771311
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile